IMCR
Immunocore Holdings PLC - ADR

512
Mkt Cap
$1.52B
Volume
278,976.00
52W High
$40.71
52W Low
$23.15
PE Ratio
-42.22
IMCR Fundamentals
Price
$29.91
Prev Close
$30.04
Open
$30.19
50D MA
$32.61
Beta
0.71
Avg. Volume
406,759.38
EPS (Annual)
-$0.707
P/B
4.00
Rev/Employee
$765,173.26
$1,320.03
Loading...
Loading...
News
all
press releases
Immunocore (NASDAQ:IMCR) Cut to "Hold" at Jefferies Financial Group
Jefferies Financial Group cut Immunocore from a "buy" rating to a "hold" rating and set a $33.00 target price on the stock. in a research note on Monday...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
What is HC Wainwright's Estimate for Immunocore Q1 Earnings?
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) - Investment analysts at HC Wainwright raised their Q1 2026 earnings per share (EPS) estimates for shares of Immunocore in a report...
MarketBeat·16d ago
News Placeholder
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Recommendation of "Moderate Buy" from Analysts
Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Get Free Report) have earned an average recommendation of "Moderate Buy" from the thirteen research firms that are covering the firm...
MarketBeat·16d ago
News Placeholder
FY2027 EPS Estimates for Immunocore Cut by HC Wainwright
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR - Free Report) - Equities researchers at HC Wainwright cut their FY2027 earnings per share (EPS) estimates for Immunocore in a report issued on...
MarketBeat·17d ago
News Placeholder
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types PR Newswire VANCOUVER...
PR Newswire·17d ago
News Placeholder
Immunocore (NASDAQ:IMCR) Downgraded by Zacks Research to "Hold"
Zacks Research cut Immunocore from a "strong-buy" rating to a "hold" rating in a research note on Wednesday...
MarketBeat·23d ago
News Placeholder
Immunocore (NASDAQ:IMCR) Given New $75.00 Price Target at Needham & Company LLC
Needham & Company LLC boosted their target price on shares of Immunocore from $71.00 to $75.00 and gave the company a "buy" rating in a report on Thursday...
MarketBeat·24d ago
News Placeholder
Immunocore Q4 Earnings Call Highlights
Immunocore (NASDAQ:IMCR) executives highlighted continued commercial momentum for KIMMTRAK and progress across a diversified pipeline during the company's fourth-quarter and full-year 2025 earnings...
MarketBeat·25d ago
News Placeholder
Immunocore (NASDAQ:IMCR) Announces Earnings Results
Immunocore (NASDAQ:IMCR - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.60) earnings per share for the quarter, missing the consensus estimate of...
MarketBeat·25d ago
News Placeholder
JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations
Jazz Pharmaceuticals beats Q4 earnings and revenue estimates as neuroscience and oncology sales climb, sending shares up 5% in after hours.
Zacks·25d ago
<
1
2
...
>

Latest IMCR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.